Correlation Between AN2 Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Tempest Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Tempest Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Tempest is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Tempest Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.18 times more return on investment than Tempest Therapeutics. However, AN2 Therapeutics is 1.18 times more volatile than Tempest Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 107.00 in AN2 Therapeutics on August 25, 2024 and sell it today you would earn a total of 27.00 from holding AN2 Therapeutics or generate 25.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Tempest Therapeutics
Performance |
| Timeline |
| AN2 Therapeutics |
| Tempest Therapeutics |
AN2 Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |